Australia's Sirtex clears U.S. regulatory hurdle for Chinese buyout
July 15, 2018 at 20:58 PM EDT
Liver cancer treatment maker Sirtex Medical said on Monday that the U.S. Federal Trade Commission cleared its $1.4 billion buyout by a Chinese consortium, clearing a major hurdle for the deal to go through.
